Search clinical trials for: Orally Disintegrating Tablet

Total 9888 results

Yonsei University

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

Dyslipidemia

Korea, Republic of
The Affiliated Hospital of Qingdao University

Recruiting

Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body

Schizophrenia | Bioequivalence

China
Pfizer
Bioshin (Shanghai) Consulting Services Co., Ltd

Completed

A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants

Acute Migraine

China
Mylan Pharmaceuticals Inc

Completed

Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg

Healthy

United States
Pfizer
Biohaven Pharmaceutical Holding Company Ltd.

Active, not recruiting

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

United States
Pfizer
Biohaven Pharmaceutical Holding Company Ltd.

Terminated

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

Temporomandibular Disorders (TMD)

United States
Vertex Pharmaceuticals Incorporated

Completed

Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years

Cystic Fibrosis

United States, United Kingdom, Canada, Australia, Germany
University of Michigan

Terminated

OPTIMA-TBI Pilot Study (OPTIMA)

Mild Traumatic Brain Injury

United States
The University of Hong Kong

Completed

Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction

Heart Failure With Preserved Ejection Fraction

Hong Kong
Adare Pharmaceuticals, Inc.

Completed

Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE)

Eosinophilic Esophagitis

Spain, United States, Belgium, Switzerland, Germany, Canada
Seasons Biotechnology (Taizhou) Co., Ltd.

Completed

Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

Major Depressive Disorder (MDD)

India
Seasons Biotechnology (Taizhou) Co., Ltd.

Completed

Single Dose Study to Evaluate Dose-proportionality of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

Major Depressive Disorder (MDD

India
Seasons Biotechnology (Taizhou) Co., Ltd.

Completed

Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

Major Depressive Disorder (MDD)

India
Genuine Research Center, Egypt
P&C Labs, Egypt

Completed

Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)

Healthy

Egypt
University Children's Hospital Basel
Permamed AG, Switzerland; Galvita AG, Switzerland

Completed

Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg Regular IVERMECTIN Tablets in Healthy Adults Under Fasting Conditions (CHILD-IVITAB)

Bioequivalence

Switzerland
National Institute of Allergy and Infectious Diseases...

Completed

The Effect of Stomach Acid on Foscarnet

HIV Infections

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg

Healthy Adult Male

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects

Healthy Adult Male

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects

Healthy Adult Male

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Withdrawn

A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form

Healthy
Peking University

Completed

Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study

Acute Schizophrenia Episode

China
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet.

Erectile Dysfunction

Singapore
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.

Erectile Dysfunction

Singapore
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition

Hypertension

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...
Aurobindo Pharma Ltd; Trident Life Sciences Ltd.

Completed

Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules

Healthy Volunteers

India
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet

Healthy

Japan
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet

Uremic Pruritus

China
Pfizer's Upjohn has merged with Mylan to form Viatris...
Aurobindo Pharma Ltd; Trident Life Sciences Ltd.

Completed

Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate Tablets

Healthy Volunteers

India
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil

Healthy

Japan
First Affiliated Hospital of Zhejiang University
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets

Improvement of Pruritus in Hemodialysis Patients

China
Bayer
Janssen Research & Development, LLC

Completed

Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on the Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 15 mg in Japanese Healthy Male Adult Subjects

Clinical Pharmacology

Japan
Bayer
Janssen Research & Development, LLC

Completed

Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects

Clinical Pharmacology

Japan
MonoSol Rx

Completed

Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets (01905/08-09)

Nausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, Postoperative

India
Takeda

Completed

A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet

Japanese Healthy Adult Male

Japan
Ferring Pharmaceuticals

Completed

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects

Nocturia

Japan
Ferring Pharmaceuticals

Completed

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects

Nocturia

Japan
One World Cannabis Ltd.

Completed

Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult Volunteers

Healthy Subjects

Israel
Eli Lilly and Company

Completed

A Study of Two Dosage Forms of LY2886721 in Healthy Participants

Healthy Volunteers

United States
Ferring Pharmaceuticals

Completed

Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Nocturia

Japan
Ferring Pharmaceuticals

Completed

Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women

Overactive Bladder

United States
Wake Forest University Health Sciences

Completed

High Pain Intervention in Cesarean Sections

Other Chronic Postoperative Pain

United States
Flex Pharma, Inc.

Terminated

A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps. (COMMIT)

Charcot-Marie-Tooth Disease

United States
Flex Pharma, Inc.

Terminated

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

Motor Neuron Disease

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fasting Condition

Healthy

India
Bayer

Completed

Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

Clinical Pharmacology

Japan
Merck KGaA, Darmstadt, Germany
Swiss Tropical & Public Health Institute

Completed

Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets (ODTs) of Praziquantel (PZQ) and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years

Healthy

Tanzania
Takeda

Completed

Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs

Gastric or Duodenal Ulcers
Ferring Pharmaceuticals

Completed

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Nocturia

United States, Canada
Takeda

Completed

Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants

Bioavailability

United States

3

Subscribe